Peptide Inhibitors for Viral Nucleic Acid Transcription

The peptide inhibitor exhibits selective activity against foreign nucleic acid molecules while sparing cellular genes. The peptide specifically targets extrachromosomal DNA and RNA viruses through its amino acid sequence structure, creating a local quality distinction between the target (foreign nucleic acids) and non-target (cellular genes). This selectivity is achieved through the peptide's specific interaction with foreign nucleic acid structures, thereby inhibiting viral replication without harmful effects on host gene expression.

The peptide inhibitor represents a novel mechanism that may not be subject to the same mutation-escape pathways as traditional small-molecule antivirals. The peptide's protein-based structure and mechanism of action (direct inhibition of foreign nucleic acid transcription/translation) provide a different evolutionary pressure profile, potentially reducing the ability of viruses to mutate escape. This approach treats viral infections with a mechanism that is difficult for viruses to counteradapt.

The peptide inhibitor specifically targets and extracts the foreign nucleic acid molecules from the cellular environment, preventing their transcription and translation. By directly eliminating the viral genetic material rather than relying on traditional antiviral mechanisms that may fail, the treatment achieves reliable viral infection reduction. This effective treatment prevents the need for antibiotic use in treating viral infections, thereby reducing the selection pressure that drives antibiotic-resistant bacteria spread.